CONGENITAL PULMONARY ALVEOLAR PROTEINOSIS - FAILURE OF TREATMENT WITH EXTRACORPOREAL LIFE-SUPPORT

被引:39
|
作者
MOULTON, SL
KROUS, HF
MERRITT, TA
ODELL, RM
GANGITANO, E
CORNISH, JD
机构
[1] UNIV CALIF SAN DIEGO, DEPT SURG, SAN DIEGO, CA 92103 USA
[2] UNIV CALIF SAN DIEGO, DEPT PATHOL, SAN DIEGO, CA 92103 USA
[3] UNIV CALIF SAN DIEGO, DEPT PEDIAT, DIV NEONATAL, SAN DIEGO, CA 92103 USA
[4] UNIV CALIF DAVIS, DEPT PEDIAT, DIV NEONATAL, DAVIS, CA 95616 USA
[5] CHILDRENS HOSP, DEPT PATHOL, SAN DIEGO, CA USA
[6] CHILDRENS HOSP, DEPT NEONATOL, SAN DIEGO, CA USA
[7] HUNTINGTON MEM HOSP, DEPT PEDIAT, DIV NEONATAL, PASADENA, CA 91105 USA
来源
JOURNAL OF PEDIATRICS | 1992年 / 120卷 / 02期
关键词
D O I
10.1016/S0022-3476(05)80448-2
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Pulmonary alveolar proteinosis, a rare disease in neonates, is characterized by the accumulation of insoluble amorphous material within the alveoli. We describe two pairs of siblings with pulmonary alveolar proteinosis in two otherwise unaffected families. All four patients were term neonates in whom severe pulmonary failure developed within hours after birth; three had mature lung profiles. Radiographic lung markings were characterized by an early granular pattern followed by lung opacification. All patients were treated with extracorporeal life support for periods of 212 to 381 hours, but none survived. Life spans ranged from 16 to 190 days. We speculate that pulmonary alveolar proteinosis in neonates results from a genetic defect in surfactant processing that may not be amenable to conventional or unconventional therapies, including extracorporeal life support.
引用
收藏
页码:297 / 302
页数:6
相关论文
共 50 条
  • [21] EXTRACORPOREAL LIFE-SUPPORT FOR STATUS-ASTHMATICUS
    SHAPIRO, MB
    KLEAVELAND, AC
    BARTLETT, RH
    CHEST, 1993, 103 (06) : 1651 - 1654
  • [22] EXTRACORPOREAL LIFE-SUPPORT FOR STATUS-ASTHMATICUS
    COOPER, DJ
    TUXEN, DV
    FISHER, MM
    CHEST, 1994, 106 (03) : 978 - 979
  • [23] NOSOCOMIAL INFECTIONS DURING EXTRACORPOREAL LIFE-SUPPORT
    SCHUTZE, GE
    HEULITT, MJ
    PEDIATRIC RESEARCH, 1994, 35 (04) : A58 - A58
  • [24] EXTRACORPOREAL LIFE-SUPPORT IN CRITICAL CARE MEDICINE
    SINARD, JM
    BARTLETT, RH
    JOURNAL OF CRITICAL CARE, 1990, 5 (04) : 265 - 278
  • [25] PREDICTORS FOR WEANING FROM EXTRACORPOREAL LIFE-SUPPORT
    BIEHL, DA
    STEWART, DL
    HAMLYN, N
    BOND, SJ
    COOK, LN
    PEDIATRIC RESEARCH, 1994, 35 (04) : A216 - A216
  • [26] Plasmapheresis for treatment of pulmonary alveolar proteinosis
    Luisetti, M.
    Rodi, G.
    Perotti, C.
    Campo, I.
    Mariani, F.
    Pozzi, E.
    Trapnell, B. C.
    EUROPEAN RESPIRATORY JOURNAL, 2009, 33 (05) : 1220 - 1222
  • [27] Development of treatment for pulmonary alveolar proteinosis
    Shiratori, M
    Takahashi, H
    INTERNAL MEDICINE, 2002, 41 (12) : 1090 - 1091
  • [28] PULMONARY ALVEOLAR PROTEINOSIS - ENDOBRONCHIAL TREATMENT
    RAMIREZR, J
    CAMPBELL, GD
    ANNALS OF INTERNAL MEDICINE, 1965, 63 (03) : 429 - +
  • [29] TREATMENT BY PULMONARY LAVAGE OF ALVEOLAR PROTEINOSIS
    KOMPALITCH, M
    VINCENT, J
    THOMAS, D
    JAGUEUX, M
    DECROIX, G
    REVUE FRANCAISE DES MALADIES RESPIRATOIRES, 1973, 1 (10): : 1052 - 1062
  • [30] ADVANCES IN TREATMENT OF PULMONARY ALVEOLAR PROTEINOSIS
    KAO, D
    WASSERMAN, K
    COSTLEY, D
    BENFIELD, JR
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1975, 111 (03): : 361 - 363